Press "Enter" to skip to content

Pfizer vaccine, to medical management; CanSino, to the elderly

The vaccine from the Chinese laboratory CanSino will greatly facilitate the vaccination of the country’s elderly and later the general population, as it is a single application, said President Andrés Manuel López Obrador.

“Yes we are going to make it easier for (the CanSino vaccine) to be a dose when it comes to the general population and the elderly, due to the transfer of the vaccine and the application,” he explained in his morning conference.

For this reason, the first doses of the vaccine that arrived in the country from the Pfizer laboratories will be used to vaccinate medical personnel, since being a population of no more than 750 thousand workers, the logistics to apply a second necessary dose is streamlined.

“For example, the Pfizer vaccine is two applications, so we are thinking more about dedicating it to medical personnel, because it is relatively easier to apply it in a thousand hospitals that are in accessible locations”, declared the President.

The president stressed that among the benefits of the CanSino vaccine is that it does not need ultracooling, which will allow access to medical personnel in inaccessible places where older people live.

He explained that to universally vaccinate older adults it is necessary to reach 300 my localities in the country, where the majority have populations of less than 300 people: “We have to go there and we will not be able to continue vaccinating until we vaccinate all seniors”.

The President gave the example of the inhabitants of Batopilas, Chihuahua, where it can only be accessed by plane, helicopter or on a road trip that lasts 8 to 10 hours and where applying a single dose of the vaccine is the most efficient.

López Obrador reported that so far no company has requested permission or carried out any procedure to acquire the coronavirus vaccine, after last Sunday he said that the private initiative will be able to acquire it abroad to sell it.

The president reiterated that he is not opposed to companies importing or selling it, or whoever has money to buy it, as long as they are not the vaccines that the federal government acquired and that they are authorized by the Federal Commission for Protection against Health Risks (Cofepris).

“Don’t be misunderstood, we are not opposed to anyone with money being able to buy the vaccine, but our responsibility is to ensure that everyone, under equal circumstances, has the right to the vaccine.

However, he assured that it will be guaranteed that the entire population has access to the vaccine for free and affirmed that there will be no political influence, since its application will be in accordance with the vaccination plan.

Coahuila and Nuevo Leon

At the beginning of the anticovid vaccination day in the north of the country, the governor of Coahuila, Miguel Riquelme thanked the federal government for sending doses so that it would be the first entity besides Mexico City to receive them. but he made it clear that they do not consider it a prize but a strategic decision for the location of the state.

At 5:00 a.m., the 8,775 doses of the vaccine left the Monterrey Airport guarded by the Army and National Guard towards the sixth military zone of Saltillo, where the first 30 vaccines were administered minutes before 10:00 a.m. the morning.

In Nuevo León, a shipment of 1,950 doses of Pfizer covid-19 vaccines arrived at air base number 14 of the Ministry of National Defense, in the municipality of Salinas Victoria.

Sedena personnel, doctors and officials from the State Health Secretariat received the Army aircraft that took off from the Mexico City airport.

The vaccines will be applied to medical personnel, nurses and administration staff of public and private hospitals.

Upon arrival, Nuevo León already has the refrigerators to keep the vaccine below 70 degrees Celsius.

Novavax will do phase 3 in Mexico

The Novavax company announced the start of its phase 3 clinical study in Mexico and the United States to evaluate the efficacy of its candidate vaccine NVX-CoV2373 against the cause of the disease d covid-19.

The biotechnology company will recruit up to 30,000 volunteers on a global scale, over 18 years of age, of which 2,000 will be from seven locations in Mexico.


With information from: Jannet López Ponce and Eduardo Mendieta

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *